(19)
(11) EP 1 223 969 A2

(12)

(88) Date of publication A3:
10.05.2002

(43) Date of publication:
24.07.2002 Bulletin 2002/30

(21) Application number: 00963073.2

(22) Date of filing: 02.10.2000
(51) International Patent Classification (IPC)7: A61K 38/39
// (A61K38/39, 31:445)
(86) International application number:
PCT/JP0006/874
(87) International publication number:
WO 0124/784 (12.04.2001 Gazette 2001/15)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 04.10.1999 AU PQ324999
15.02.2000 AU PQ564300

(71) Applicant: FUJISAWA PHARMACEUTICAL CO., LTD.
Osaka-shiOsaka 541-8514 (JP)

(72) Inventors:
  • MORIGUCHI, AkiraFujisawa Pharmaceutical Co., Ltd.
    Osaka-shi,Osaka 541-8514 (JP)
  • FURUICHI, Yasuhisa,Fujisawa Pharma. Co., Ltd.
    Osaka-shi,Osaka 541-8514 (JP)
  • KATSUTA, KiyotakaFujisawa Pharmaceutical Co. Ltd.
    Osaka-shi,Osaka 541-8514 (JP)
  • MAEDA, MasashiFujisawa Pharmaceutical Co., Ltd.
    Osaka-shi,Osaka 541-8514 (JP)
  • SATO, NatsukiFujisawa Pharmaceutical Co., Ltd.
    Osaka-shi,Osaka 541-8514 (JP)

(74) Representative: Gille Hrabal Struck Neidlein Prop Roos 
Patentanwälte,Brucknerstrasse 20
40593 Düsseldorf
40593 Düsseldorf (DE)

   


(54) COMBINED USE OF A PLASMINOGEN ACTIVATOR AND IL-2 INHIBITORS FOR NEUROPROTECTION